Article
Published 31 Jul 2025
Alberta Securities Commission Releases Reasons For Cease-Trading Retroactive Poison Pill
Blake, Cassels & Graydon LLP
Your search returned 1,072 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 29 Jul 2025
Mr. Grenon's Legendary RRSP And Its Implications For Fund Manufacturers
Borden Ladner Gervais LLP
Article
Published 29 Jul 2025
Co-investment Trends In 2025: Continuation Vehicles, Warehousing Costs And Fees
Torys LLP
Article
Published 28 Jul 2025
New CSA Amendments Regarding Investments In Crypto Assets Come Into Force
Bennett Jones LLP
Article
Published 21 Jul 2025
Proposed Enhancements To The Regulatory Framework For Exchange-traded Funds By The Canadian Securities Administrators
Osler, Hoskin & Harcourt LLP
Article
Published 21 Jul 2025
La CVMO met la touche finale aux règles sur la distribution de fonds récupérés aux investisseurs lésés
Blake, Cassels & Graydon LLP
Article
Published 10 Jul 2025
Seeding The Future: Why GP Seeding Is Gaining Ground In Private Capital
Torys LLP
Article
Published 9 Jul 2025
Les Opportunités De Financement Pour Les Autochtones Sous Forme De Prises De Participation — Une Tendance Marquée En 2025
McCarthy Tétrault LLP
Article
Published 8 Jul 2025
From Traditional Commercial Banking To Asset-based Lending: Key Considerations For Businesses Contemplating The Switch
Torkin Manes LLP
Article
Published 2 Jun 2025
Collateral Controversy: The J. Crew Manoeuvre And The Fight Over Loan Agreement Loopholes
Aird & Berlis LLP
Article
Published 26 May 2025
CSA Finalizes Amendments To Public Crypto Asset Fund Rules
Borden Ladner Gervais LLP
Article
Published 30 Apr 2025
Qu'arrive-t-il Lorsqu'un Mandataire Manque À Ses Obligations Fiduciaires En Vertu D'une Procuration?Observations Tirées De L'affaire Holmes v. Modry
Miller Thomson LLP
Article
Published 15 Apr 2025
What Happens When An Attorney Breaches Fiduciary Duties Under A POA? Insights From Holmes v. Modry
Miller Thomson LLP
Article
Published 2 Apr 2025
35 Years Of ETFs: The Evolution Of A Canadian Innovation
Borden Ladner Gervais LLP
Article
Published 6 Mar 2025
ONR Limited Partnership: What Can't An Agent Do?
McCarthy Tétrault LLP
Article
Published 20 Feb 2025
Nouvelles normes de conduite commerciale en dérivés pour les sociétés non canadiennes
Fasken (French)
Article
Published 20 Feb 2025
New Derivatives Business Conduct Standards For Non-Canadian Firms
Fasken
Article
Published 7 Feb 2025
ASC Grants Novel Exemptive Relief To Permit A Family Office To Act As Dealer, Adviser And Investment Fund Manager
Borden Ladner Gervais LLP
Article
Published 24 Jan 2025
Exit Strategies: The Rise Of Co-investments
Torys LLP
Article
Published 24 Jan 2025
Pension Governance Considerations
Torys LLP